About: http://data.cimple.eu/news-article/e157b8c5474aa9dd947776c23b0344b07014f508d643bf79d592763c

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/e157b8c5474aa9dd947776c23b0344b07014f508d643bf79d592763c Goto Sponge Distinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	US biotech firm Novavax on Monday said it had delayed plans to seek authorization for its Covid vaccine candidate, a setback for developing countries hoping the injection would soon be available. The company now hopes to file for authorization in the US and Europe in the third quarter of 2021, it said in a statement, sending shares tumbling 12 percent. Novavax's vaccine is key to the Covax program, which was set up to try to ensure poor countries have equitable access to vaccines to combat the coronavirus pandemic. Its NVX-CoV2373 vaccine candidate demonstrated 100 percent protection against severe disease in a Phase 3 clinical trial in Britain, with 89.7 percent efficacy against any form of the disease. It uses a piece of the SARS-CoV-2 virus called the spike protein, which the company mass-produces inside insect cells, and can be stored at regular refrigeration temperatures. Novavax also said Monday it had had positive results from preclinical studies of a shot combining its influenza and Covid vaccine candidates. The company said a study, which will now undergo peer review, showed that the shot produced strong levels of antibodies against both diseases in ferrets and hamsters. "Despite low rates during the Covid-19 pandemic, influenza remains a significant risk to global public health and the need for versatile, more effective vaccines is as important as ever, including against the flu," said Gregory Glenn, the company's president of R&D. The new vaccine combines NanoFlu and NVX-CoV2373. Hamsters that were vaccinated and then deliberately infected with the coronavirus retained their body weight compared to those that received a placebo. Lung samples taken from the immunized animals after they were put down showed they were Covid-free. ia/jm/bgs/jh
schema:headline	Novavax delays Covid vaccine authorization request
schema:mentions	Novavax Research and development Developing country USA Gymnastics Clinical trial Insect Placebo Protein Public health Antibody Ia (cuneiform) Influenza European Union Pandemic Virus Coronavirus disease Vaccine Coronavirus Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Refrigeration Pope Gregory I
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-05-11 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	83 (xsd:integer)
http://data.cimple...tology#hasEmotion	anger

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software